Filoviruses: recent advances and future challenges

scientific article published in December 2006

Filoviruses: recent advances and future challenges is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1586/14787210.4.6.917
P8608Fatcat IDrelease_nkyy4drkfbczvp6ecrtsspcrza
P698PubMed publication ID17181407
P5875ResearchGate publication ID6619676

P2093author name stringMike Bray
Richard Pilch
P2860cites workEbola virus: new insights into disease aetiopathology and possible therapeutic interventionsQ35895035
Filovirus assembly and buddingQ36346797
Pre- and postexposure prophylaxis of Ebola virus infection in an animal model by passive transfer of a neutralizing human antibodyQ39683688
Functional characterization of Ebola virus L-domains using VSV recombinantsQ40422906
Epitopes involved in antibody-mediated protection from Ebola virusQ40625468
Evaluation of immune globulin and recombinant interferon-alpha2b for treatment of experimental Ebola virus infectionsQ44089771
Ebola hemorrhagic fever and septic shockQ44090615
Dose-response study of recombinant factor VIIa/tissue factor inhibitor recombinant nematode anticoagulant protein c2 in prevention of postoperative venous thromboembolism in patients undergoing total knee replacementQ49168123
Multiple Ebola Virus Transmission Events and Rapid Decline of Central African WildlifeQ22299362
Gene-specific countermeasures against Ebola virus based on antisense phosphorodiamidate morpholino oligomers.Q25256700
Recombinant nematode anticoagulant protein c2, an inhibitor of the tissue factor/factor VIIa complex, in patients undergoing elective coronary angioplastyQ28196508
Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infectionQ28588877
Ebola virus VP40 late domains are not essential for viral replication in cell cultureQ33911884
Experimental therapy of filovirus infectionsQ33957838
Mechanisms underlying coagulation abnormalities in ebola hemorrhagic fever: overexpression of tissue factor in primate monocytes/macrophages is a key eventQ33974171
Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeysQ33974706
Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenavirusesQ34317031
Postexposure protection against Marburg haemorrhagic fever with recombinant vesicular stomatitis virus vectors in non-human primates: an efficacy assessmentQ34519791
Postexposure protection of guinea pigs against a lethal ebola virus challenge is conferred by RNA interferenceQ34526756
Ebola virus: the role of macrophages and dendritic cells in the pathogenesis of Ebola hemorrhagic feverQ34557675
Ebola virus VP35 protein binds double-stranded RNA and inhibits alpha/beta interferon production induced by RIG-I signalingQ34648134
Ebola virus VP24 binds karyopherin alpha1 and blocks STAT1 nuclear accumulationQ34648461
Drotrecogin alfa (recombinant human activated protein C) for the treatment of severe sepsisQ35128436
Activated protein C in sepsis: emerging insights regarding its mechanism of action and clinical effectivenessQ35786305
Pathogenesis of filoviral haemorrhagic feversQ35853406
P433issue6
P407language of work or nameEnglishQ1860
P304page(s)917-921
P577publication date2006-12-01
P1433published inExpert Review of Anti-infective TherapyQ15734432
P1476titleFiloviruses: recent advances and future challenges
P478volume4

Reverse relations

cites work (P2860)
Q38264960Clinical presentation and management of severe Ebola virus disease
Q34536774Induction of caspase activation and cleavage of the viral nucleocapsid protein in different cell types during Crimean-Congo hemorrhagic fever virus infection
Q37332576Interferon and cytokine responses to Crimean Congo hemorrhagic fever virus; an emerging and neglected viral zonoosis
Q30205763Recent advances in research on Crimean-Congo hemorrhagic fever

Search more.